N@N

Andrew Berens Maintained (ZYME) at Hold with Increased Target to $10 on, Jan 20th, 2023

^{Published on 2024-10-28 01:01:33 - WOPRAI, Andrew Berens}
 

Andrew has made no other calls on ZYME in the last 4 months.

There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Robert Burns of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $8 on, Wednesday, January 4th, 2023
• Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022

These are the ratings of the 3 analyists that currently disagree with Andrew

• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022
• Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $18 on, Monday, October 24th, 2022
• Nick Abbott of "Wells Fargo" Initiated at Buy with Decreased Target to $9 on, Tuesday, October 4th, 2022